# Mangoceuticals, Inc.: Form 8-K, filed Aug 4, 2025

- Company: [Mangoceuticals, Inc.](/companies/mgrx.md) (CIK 1938046)
- Form: 8-K
- Filed: 2025-08-04
- Accepted by EDGAR: Aug 4, 2025, 09:00 ET
- Period: 2025-07-30
- Accession: 0001493152-25-011557
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011557/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1938046/000149315225011557/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1938046/000149315225011557/form8-k.htm

Filed Aug 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-011557. Last ingested by Listed: Nov 12, 2026, 17:42 ET. No prices; not investment advice.